Guy Handley, MD FACP
Department of Infectious Diseases, Infection Control, and Employee Health, Division of Internal Medicine
Present Title & Affiliation
Primary Appointment
Assistant Professor, Infectious Diseases, Infection Control & Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas
Dual/Joint/Adjunct Appointment
Assistant Professor, Infectious Diseases, Infection Control & Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas
Education & Training
Degree-Granting Education
| 2015 | University of Alabama School of Medicine, US, Medicine, Doctor of Medicine |
| 2011 | Rhodes College, US, Biology, Bachelor of Science |
Postgraduate Training
| 2026-2026 | IDSA Advanced Antimicrobial Stewardship Curriculum, Infectious Diseases Society of America (IDSA) Academy |
| 2025-2026 | Clinical Safety and Effectiveness (CS&E) Program, Cohort 37, UT MD Anderson, Houston, Texas |
| 2021-2021 | Physician Educator Certificate Program (PECP), UT Health Houston McGovern Medical School, Houston, Texas |
| 2019-2021 | Postgraduate Fellow, Infectious Diseases, McGovern Medical School UT Health/MD Anderson Cancer Center, Houston, Texas |
| 2016-2018 | Residency, Internal Medicine, Ochsner Clinic Foundation |
| 2015-2016 | Internship, Internal Medicine, Ochsner Clinic Foundation |
Licenses & Certifications
| 2025 | Georgia Composite Medical Board |
| 2025 | Alabama Board of Medical Examiners |
| 2025 | Oklahoma State Board of Medical Licensure |
| 2025 | Louisiana State Board of Medical Examiners |
| 2025 | Tennessee Board of Medical Examiners |
| 2025 | Arizona Medical Board |
| 2025 | Mississippi State Board of Medical Licensure |
| 2024 | Texas Medical Board |
| 2021 | ABIM Infectious Diseases Certification |
| 2018 | ABIM Internal Medicine Certification |
| 2018 | DEA Controlled Substance License |
Experience & Service
Faculty Academic Appointments
Assistant Professor, Internal Medicine, Infectious Disease and International Medicine, University of South Florida Morsani College of Medicine, Tampa, Florida, 2021 - 2024
Associate Lecturer, Ochsner Clinical School, 2018 - 2021
Administrative Appointments/Responsibilities
Director, Antimicrobial Stewardship Program, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2025 - Present
Associate Chief Infection Control Officer, Infectious Diseases, Infection Control & Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2024 - Present
Intramural Institutional Committee Activities
Member, Infectious Diseases Operations Committee, The University of Texas MD Anderson Cancer Center, 2026 - Present
Chair, Antimicrobial Stewardship Advisory Committee, The University of Texas MD Anderson Cancer Center, 2025 - Present
Vice Chair, Infection Control Committee, The University of Texas MD Anderson Cancer Center, 2025 - Present
Member, Infectious Diseases Engagement & Wellness Committee, The University of Texas MD Anderson Cancer Center, 2025 - Present
Chair, HLD & Sterilization Council, The University of Texas MD Anderson Cancer Center, 2025 - Present
Member, USF Infectious Diseases Fellowship Program Evaluation Committee, University of South Florida, 2022 - 2024
Member, University of South Florida/Tampa General Hospital Infectious Diseases Quality Committee, University of South Florida, 2022 - 2024
Member, USF Infectious Diseases Lasher Advanced Practice Provider Search Committee, University of South Florida, 2022 - 2024
Member, USF Infectious Diseases New Faculty Search Committee, University of South Florida, 2022 - 2023
Member, USF Infectious Diseases COVID-19 Response Committee, University of South Florida, 2021 - 2024
Member, Infectious Diseases Chief Fellow, Program Evaluation Committee, McGovern Medical School UT Health/MD Anderson Cancer Center Infectious Diseases Fellowship, UT Health Houston McGovern Medical School, 2020 - 2021
Member, Chief Medical Resident, Core Competency Committee, Ochsner Clinic Foundation Internal Medicine Residency, Ochsner Clinic Foundation, 2018 - 2019
Member, Chief Medical Resident, Program Evaluation Committee, Ochsner Clinic Foundation Internal Medicine Residency, Ochsner Clinic Foundation, 2018 - 2019
Extramural Institutional Committee Activities
Member, Tampa General Hospital Antimicrobial Subcommittee, Tampa General Hospital, 2023 - 2024
Primary Author, Epstein Barr Virus (EBV) Surveillance and PTLD Prevention; 2023 Guideline Revision, Moffitt Cancer Center BMT Clinical Standards Committee, Moffitt Cancer Center, 2023
Primary Author, Post Anti-CD19 Chimeric Antigen Receptor T-cell Therapy Care; Initial Guideline, Tampa General Hospital BMT and Cellular Therapy Oncology Committee, Tampa General Hospital, 2023
Primary Author, HHV-6 Management of Reactivation in AlloHCT; 2022 Guideline Revision, Moffitt Cancer Center BMT Clinical Standards Committee, Moffitt Cancer Center, 2022
Primary Author, Post-Transplant Care - Autologous Transplant, Initial Guideline, Tampa General Hospital BMT and Cellular Therapy Oncology Committee, Tampa General Hospital, 2022
Editorial Activities
Ad-hoc Reviewer, Pediatric Medicine, 2023 - Present
Ad-hoc Reviewer, American Journal of Tropical Medicine & Hygiene, 2023 - Present
Ad-hoc Reviewer, Clinical Transplantation, 2023 - Present
Ad-hoc Reviewer, ID Cases, 2022 - Present
Ad-hoc Reviewer, Clinical Infectious Diseases, 2022 - Present
Ad-hoc Reviewer, Reviews in Medical Virology, 2022 - Present
Ad-hoc Reviewer, Open Forum Infectious Diseases, 2021 - Present
Ad-hoc Reviewer, BMC Infectious Diseases, 2021 - Present
Honors & Awards
| 2025 - Present | Fellow of the American College of Physicians, American College of Physicians |
| 2024 - 2025 | Castle Connolly Rising Star, Castle Connolly |
| 2023 | Faculty Teacher of the Year Award, USF Health Division of Infectious Disease |
| 2020 - 2021 | Chief Fellow, McGovern Medical School UT Health |
| 2020 | IDWeek 2020 Trainee Award, Infectious Diseases Society of America |
| 2018 - 2019 | Chief Medical Resident, Ochsner Clinic Foundation |
| 2017 | Ochsner Clinical School Resident Teaching Award, Ochsner Clinical School |
| 2012 | UAB Department of Medicine Summer Internship Program Award, University of Alabama School of Medicine |
| 2010 | Beta Beta Beta Biology Honor Society |
| 2010 | Mortar Board, Rhodes College, Torch Chapter |
| 2010 | Omicron Delta Kappa, Rhodes College, Phi Circle |
| 2007 - 2011 | Morse Fellowship Award, Rhodes College |
| 2007 | Eagle Scout, Boy Scouts of America |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2026. Urinalysis Paralysis: The Complicated Diagnosis of UTI in Patients with Cancer. Invited. Internal Medicine and Cancer Survivorship Grand Rounds. Houston, Texas, US.
- 2026. Infection Prevention and Control in a Comprehensive Cancer Center. Invited. Houston, Texas, US.
- 2026. Infectious Diseases Core Curriculum: Infection Prevention and Control in a Comprehensive Cancer Center. Invited. Houston, Texas, US.
- 2025. Urinary Tract Infection and Asymptomatic Bacteriuria: Clinical Update and Pitfalls. Invited. Clinical and Research Lecture. Houston, Texas, US.
- 2024. USF ID Fellowship Bootcamp Series: Central Nervous System Infections. Invited. Tampa, Florida, US.
- 2024. USF Pulmonary Critical Care Medicine Core Curriculum: Mold Pneumonia in Oncology Patients. Invited. Tampa, Florida, US.
- 2024. USF Gynecology/Oncology Fellowship Didactic Series: Neutropenic Fever. Invited. Tampa, Florida, US.
- 2024. USF ID Fellowship Lecture Series: Pneumocystis. Invited. Tampa, Florida, US.
- 2024. UAB Lunch and Learn: HHV-6 and Allogeneic Bone Marrow Transplantation. Invited. Birmingham, Alabama, US.
- 2024. USF Gynecology/Oncology Fellowship Didactic Series: Sepsis. Invited. Tampa, Florida, US.
- 2024. USF ID Fellowship Lecture Series: HHV-6 and Allogeneic Bone Marrow Transplantation. Invited. Tampa, Florida, US.
- 2024. USF ID Fellowship Lecture Series: Mold Pneumonia in Oncology Patients. Invited. Tampa, Florida, US.
- 2023. OU Health (Oklahoma) Infectious Diseases Lecture Series: HHV-6 and Allogeneic Bone Marrow Transplantation. Invited. Oklahoma City, Oklahoma, US.
- 2023. USF ID Fellowship Bootcamp Series: Central Nervous System Infections. Invited. Tampa, Florida, US.
- 2023. USF ID Fellowship Board Review Series: Infections Immunocompromised Hosts. Invited. Tampa, Florida, US.
- 2023. Grand Rounds Lecture Series: EBV: Mononucleosis, HLH and Lymphoproliferative Disease. Invited. University of South Florida Department of Internal Medicine Grand Rounds. Tampa, Florida, US.
- 2023. USF ID Fellowship/USF Microbiology Department Joint Multidisciplinary Conference: Cytomegalovirus (CMV): Microbiology and Immune Modulation. Invited. Tampa, Florida, US.
- 2023. UTHSC (Tennessee) Pulmonary Critical Care Medicine Core Curriculum: Select Fungal Pneumonias in Oncology Patient. Invited. Memphis, Tennessee, US.
- 2023. USF Pulmonary Critical Care Medicine Core Curriculum: Pneumocystis Pneumonia. Invited. Tampa, Florida, US.
- 2023. USF ID Fellowship Lecture Series: LCMV and Prion Disease. Invited. Tampa, Florida, US.
- 2023. Transplant ID Journal Club: Effect of Prophylactic Letermovir on Late CMV-Related Mortality After Allogeneic Stem Cell Transplant. Invited. Tampa, Florida, US.
- 2022. USF ID Fellowship Bootcamp Series: ID Emergencies. Tampa, Florida, US.
- 2022. USF ID Fellowship Board Review Series: Central Nervous System Infections. Invited. Tampa, Florida, US.
- 2022. Transplant ID Journal Club: Effect of Prophylactic Foscarnet on HHV-6 Reactivation and Encephalitis. Invited. Tampa, Florida, US.
- 2022. USF ID Fellowship Lecture Series: EBV: Mononucleosis, HLH and Lymphoproliferative Disease. Invited. Tampa, Florida, US.
Regional Presentations
- 2024. HHV-6 and Allogeneic Bone Marrow Transplantation. Invited. New Orleans Citywide Infectious Disease Conference. New Orleans, Louisiana, US.
National Presentations
- 2025. Guidelines Update-HHV-6. Invited. Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR. Honululu, Hawaii, US.
International Presentations
- 2025. Approach to Post-HSCT CNS Viral Infection. Invited. ON-INTENSE-ID 2025. Kolkata, IN.
Selected Publications
Peer-Reviewed Articles
- Pasikhova Y, Snyder M, Morrison A, Handley G, Syed M, Cannella AP. Nontuberculous Mycobacterial Infections at a National Cancer Institute-Designated Comprehensive Cancer Center in Florida. Open Forum Infect Dis 13(8):ofag467, 2026. e-Pub 2026. PMID: 42568877.
- Shropshire WC, Borjan J, Fonseca IY, Pham K, Guerrero M, Liboro, K, Young A, Chung JK, Wu CT, Manzanares Jr A, Bhatti MM, Vuong NN, Handley G, Spallone A, Chemaly RF, Khan A, Shelburne S. Clinical and genomic determinants associated with emergent ceftazidime-avibactam plus aztreonam non-susceptibility in ceftazidime-avibactam resistant Escherichia coli. Antimicrob Agents Chemother 70(5):e0186025, 2026. e-Pub 2026. PMID: 41870042.
- Handley G, Powell J, Kontoyiannis DP, Feldman A, Bhatti M, Chemaly RF, Spallone A. A decade of change: evolving epidemiology of invasive pulmonary mold infections in hematologic malignancy patients from a longitudinal infection control surveillance program. Infect Control Hosp Epidemiol 47(6):1-3, 2026. e-Pub 2026. PMID: 42011878.
- Kornblum, DS, Katzman, JH, Velez, AP, Zhang, Y, Abdallah, E, Handley, G, Nazef, C, Trejo Bittar, HE, Sokol, L, Ledford, D, Greene, J. A Fatal Convergence: HLH, Disseminated MAC, and Opportunistic Fungal Infections in an Immunocompromised Host. Infectious Diseases in Clinical Practice 34(2), 2026. e-Pub 2026.
- Borjan J, Bhatti MM, Vuong NN, Handley G, Spallone A. Blood Culture Stewardship Efforts at a Comprehensive Cancer Center Reduced Isolation of Skin Flora Contaminants Without Compromising Patient Care. Microbiol Infect Dis AMJ 3:44-46, 2025. e-Pub 2025.
- Kampouri, E, Handley, GH, Phan, TL, Lee, YJ, Shaw, R, Carpenter, P, Dadwal, SS, Chemaly, RF, Papanicolaou, GA, Ogata, M, Boeckh, MJ, Zerr, DM, Hill, JA. American Society for Transplantation and Cellular Therapy Series #9. Transplantation and Cellular Therapy 31(8):480-493, 2025. e-Pub 2025. PMID: 40409689.
- Handley, GH, Yepes, A, Eliassen, E, Dominguez, G, Pasikhova, Y, Klinkova, O, Baluch, A, Febres-Aldana, A, Alsina, M, Elmariah, H, Khimani, F, Hansen, DK, Freeman, C, Jain, MD, Locke, FL, Lazaryan, A, Liu, HD, Mishra, A, Mirza, AS, Nishihori, T, Ochoa, L, Perez, LE, Pidala, J, Castaneda Puglianini, OA, Nieder, M, Perna, F, Kim, J, Bejanyan, N, Faramand, R. Outcomes of Haploidentical Stem Cell Transplant Recipients With HHV-6B Reactivation. Open Forum Infectious Diseases 11(10), 2024. e-Pub 2024. PMID: 39411216.
- Pearson EM, Handley G, Greene J. Concurrent Zoster Sine Herpete and Hepatosplenic Fungal Infection in a Cancer Patient: A Case Report. Cureus 16(10):e72117, 2024. e-Pub 2024. PMID: 39574981.
- Khawaja F, Ahmed S, Iyer SP, Sassine J, Handley G, Prakash R, VanWierren T, Jackson J, Zubovskaia A, Ramdial J, Rondon G, Patel KK, Spallone A, Ariza-Heredia EJ, Mulanovich V, Angelidakis G, Jiang Y, Chemaly RF. Cytomegaloviral Infections in Recipients of Chimeric Antigen Receptor T-Cell Therapy: An Observational Study With Focus on Oncologic Outcomes. Open Forum Infect Dis 11(8):ofae422, 2024. e-Pub 2024. PMID: 39086466.
- Handley, GH, Greene, J, Cannella, AP, Velez, AP, Shah, S, Pasikhova, Y. Real-world Experience of Posaconazole Therapeutic Drug Monitoring in Oncology Patients. Open Forum Infectious Diseases 11(5), 2024. e-Pub 2024. PMID: 38680607.
- Handley G, Greene J, Cannella AP, Velez AP, Shah S, Pasikhova Y. Real-world Experience of Posaconazole Therapeutic Drug Monitoring in Oncology Patients: Clinical Implications of Hypoalbuminemia as a Predictor of Subtherapeutic Posaconazole Levels. Open Forum Infect Dis 11(5):ofae185, 2024. e-Pub 2024. PMID: 38680607.
- Graeter A, Lee D, Handley G, Baluch A, Klinkova O. Chronic disseminated candidiasis in a patient with acute leukemia - an illustrative case and brief review for clinicians. BMC Infect Dis 24(1):296, 2024. e-Pub 2024. PMID: 38448809.
- Velez AP, Handley G, Morison A, Katzman JH, Kinkhova O, Quiltz R, Greene J, Pasikhova Y. Safety and Outcomes With Combination Therapy With Sarilumab and Baricitinib for Severe COVID-19 Respiratory Infection in Cancer Patients. Cancer Control 30:10732748231205864, 2023. e-Pub 2023. PMID: 37817417.
- Emanuel N, Siddique N, Greene J, Pasikhova Y, Morrison A, Ledbetter M, Handley G. Nocardia niwae Disseminated Nocardiosis: A Novel Species Presenting Concurrently With Lung Adenocarcinoma. Cureus 14(11):e31246, 2022. e-Pub 2022. PMID: 36505126.
- Baluch A, Handley G, Ludlow S, Morrison A, Velez A, Rojas MC, Pasikhova Y. Disseminated Toxoplasmosis in an Allogeneic Hematopoietic Stem Cell Transplant Recipient: A Case Report and Review of the Current Literature. Cureus 14(9):e29185, 2022. e-Pub 2022. PMID: 36259018.
- Handley G, Hand J. Adverse Effects of Immunosuppression: Infections. Handb Exp Pharmacol 272:287-314, 2022. e-Pub 2022. PMID: 34671868.
- Handley G, Khawaja F, Kondapi DS, Lee HJ, Kaufman GP, Neelapu SS, Fayad LE, Tummala S, Chi L, Strati P, Mulanovich VE. Human herpesvirus 6 myelitis after chimeric antigen receptor T-cell therapy. Int J Infect Dis 112:327-329, 2021. e-Pub 2021. PMID: 34600133.
- Handley G, Pankow S, Bard JD, Yee R, Nigo M, Hasbun R. Distinguishing cytomegalovirus meningoencephalitis from other viral central nervous system infections. J Clin Virol 142:104936, 2021. e-Pub 2021. PMID: 34352616.
- Wells JM, Jackson PL, Viera L, Bhatt SP, Gautney J, Handley G, King RW, Xu X, Gaggar A, Bailey WC, Dransfield MT, Blalock JE. A Randomized, Placebo-controlled Trial of Roflumilast. Effect on Proline-Glycine-Proline and Neutrophilic Inflammation in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 192(8):934-42, 2015. e-Pub 2015. PMID: 26151090.
- Wells JM, O'Reilly PJ, Szul T, Sullivan DI, Handley G, Garrett C, McNicholas CM, Roda MA, Miller BE, Tal-Singer R, Gaggar A, Rennard SI, Jackson PL, Blalock JE. An aberrant leukotriene A4 hydrolase-proline-glycine-proline pathway in the pathogenesis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 190(1):51-61, 2014. e-Pub 2014. PMID: 24874071.
Review Articles
- Makovich Z, Radosavljevic I, Chapyala S, Handley G, Pena L, Mok S, Friedman M. Rationale for Hepatitis C Virus Treatment During Hematopoietic Stem Cell Transplant in the Era of Novel Direct-Acting Antivirals. Dig Dis Sci 69(9):3488-3500, 2024. e-Pub 2024. PMID: 38990268.
- Kampouri E, Handley G, Hill JA. Human Herpes Virus-6 (HHV-6) Reactivation after Hematopoietic Cell Transplant and Chimeric Antigen Receptor (CAR)- T Cell Therapy: A Shifting Landscape. Viruses 16(4), 2024. e-Pub 2024. PMID: 38675841.
- Lemay, D, Handley, GH, Baluch, A, Greene, JN. Adenovirus Enterocolitis in Hematopoietic Stem Cell Transplant Patients. Infectious Diseases in Clinical Practice 31(1), 2023. e-Pub 2023.
- Handley G. Current Role of Prospective Monitoring and Preemptive and Prophylactic Therapy for Human Herpesvirus 6 After Allogeneic Stem Cell Transplantation. Open Forum Infect Dis 9(8):ofac398, 2022. e-Pub 2022. PMID: 36004309.
- Handley G, Hasbun R, Okhuysen P. Human herpesvirus 6 and central nervous system disease in oncology patients: A retrospective case series and literature review. J Clin Virol 136:104740, 2021. e-Pub 2021. PMID: 33548682.
Abstracts
- Wu CT, Handley G, Nguyen-Coleman KCT, Ellis N, Shropshire W, Chang CC, Ajami N, Richter AG, Leadon L, Berkheiser M, Shelburne S, Spallone A. Utilization of Analytics Software and Whole Genome Sequencing to Identify an Environmental Legionella Cluster. SHEA Spring Conference 2026, 2026. e-Pub 2026.
- Spallone A, Handley G, Bhatti M. Emerging opportunist or clinical harbinger? A review of Candida kefyr cases in cancer patients. SHEA Spring Conference 2026, 2026. e-Pub 2026.
- Feldman A, Bhatti M, Powell J, Handley G, Spallone A. One Year Evaluation of a Targeted Candida auris Screening Program at a Comprehensive Cancer Center. SHEA Spring Conference 2026, 2026. e-Pub 2026.
- Handley G, Ohashi Y, Shafat T, Lopez V, Daher M, Spallone A, Rondon G, Mehta RS, Champlin RE, Shpall EJ, Khawaja F, Chemaly RF. Human Herpesvirus 6 Reactivation within the First Year after Haploidentical Transplantation: Experience from a Major Cancer Center. TANDEM: Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR 2026, 2026. e-Pub 2026.
- Schlaeffer-Yosef T, Khawaja F, Shafat T, Shigle TL, Daher M, Lopez V, Rondon G, Shpall EJ, Champlin RE, Ariza Heredia E, Spallone A, Handley G, Chemaly RF. Cytomegalovirus End-Organ Disease after Allogenic Hematopoietic Cell Transplant: Descriptive and Comparative Analysis in the Era of Letermovir Prophylaxis. TANDEM: Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR 2026, 2026. e-Pub 2026.
- Angelidakis G, Khawaja F, Zubovskaia A, Sassine J, Ramdial JL, Ahmed S, Iyer SP, Rondon G, Handley G, Van Wierren T, Ariza Heredia E, Spallone A, Shpall EJ, Chemaly RF. Comparing Infectious Complications Following CD19 Chimeric Antigen Receptor T cell Therapy and Autologous Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies. TANDEM: Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR 2026, 2026. e-Pub 2026.
- Handley G, Borjan J, Vuong N, Bhatti M, Hosing C, Marin D, Popat UR, Champlin RE, Shpall EJ, Alousi AA, Chemaly RF, Spallone A. Development of a Pilot Program to Reduce Nitazoxanide Utilization at a Major Cancer Center in Patients with Discordant Norovirus Testing. TANDEM: Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR 2026, 2026. e-Pub 2026.
- Ohashi Y, Chemaly RF, Khawaja F, Daher M, Spallone A, Shafat T, Ariza Heredia E, Handley G. Factors Associated with Human Herpesvirus 6 DNAemia Among Allogeneic Hematopoietic Cell Transplant Recipients in the Modern Era. IDWeek 2025, 2026. e-Pub 2026.
- Borjan J, Bhatti MM, Vuong NN, Handley G, Spallone A. Blood Culture Stewardship Efforts at a Comprehensive Cancer Center Reduced Isolation of Skin Flora Contaminants Without Compromising Patient Care. IDWeek 2025, 2026. e-Pub 2026.
- Vuong NN, Chung J, Dai J, Borjan J, Dailey Garnes NJ, Spallone A, Handley G. Assessing Documented Beta-lactam Allergies at a Large Comprehensive Cancer Hospital. IDWeek 2025, 2026. e-Pub 2026.
- Patel A, Nazef C, Shah S, Velez A, Handley G, Pasikhova Y. Nocardia Infections in Oncology Patients: Risk Factors and Patterns of Resistance. IDWeek 2025, 2026. e-Pub 2026.
- Feldman A, Cantu S, Poths R, Powell J, Handley G, Spallone A. Setting the Standard: Developing a High-Consequence Infectious Disease Preparedness Policy for a Comprehensive Cancer Hospital. SHEA Spring Conference 2025, 2025. e-Pub 2025.
- Feldman A, Bhatti M, Poths R, Powell J, Handley G, Spallone A. Implementing a Candida auris Screening Program at a Comprehensive Cancer Center. SHEA Spring Conference 2025, 2025. e-Pub 2025.
- Wu CT, Handley G, Shropshire W, Cantu S, Powell J, Bhatti M, Shelburne S, Spallone A. Using Oxford Nanopore Sequencing to Investigate Potential Plasmid Transmission of the blaNDM-5 Gene. SHEA Spring Conference 2025, 2025. e-Pub 2025.
- Pasikhova Y, Snyder M, Morrison A, Handley G, Syed M, Cannella AP. Non-Tuberculosis Mycobacterial Infections at a National Cancer Institute-Designated Comprehensive Cancer Center in Florida. IDWeek 2024, 2025. e-Pub 2025.
- Handley G, Greene J, Cannella AP, Velez A, Shah S, Katzman JH, Pasikhova Y. Fungal Pneumonia and Severe Neutropenia: Risk Factors for Increased 90 Day Mortality. IDWeek 2024, 2025. e-Pub 2025.
- Handley G, Shah S, Bruning R, Katzman JH, Greene J, Pasikhova Y. Shifting Susceptibilities and Clinical Outcomes of Oncology Patients with Streptococcus mitis/oralis Bacteremia. IDWeek 2024, 2025. e-Pub 2025.
- Baez A, Handley G, Mokhtari S, Shah S, Phuoc V, Greene J. Disseminated Cryptococcus neoformans Mimicking Central Nervous System Progression of Diffuse Large B-cell Lymphoma. Society for Neuro-Oncology's 29th Annual Meeting and Education Day, 2024. e-Pub 2024.
- Yepes A, Faramand RG, Bejanyan N, Nishihori T, Locke FL, Jain MD, Nieder ML, Elmariah H, Khimani F, Liu H, Mishra A, Perez LE, Alsina M, Castaneda O, Hansen DK, Freeman CL, Ochoa L, Pidala JA, Perna F, Mirza AS, Eliassen E, Dominguez G, Lazaryan A, Klinkova OV, Baluch A, Pasikhova Y, Handley G. Outcomes of Haploidentical Stem Cell Transplant Recipients with HHV-6 Reactivation Receiving Antiviral Therapy. TANDEM: Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR 2024, 2024. e-Pub 2024.
- Pasikhova Y, Greene J, Morrison AR, Handley G. Real World Experience of Posaconazole Therapeutic Drug Monitoring in Oncology Patients: Clinical Implications of Hypoalbuminemia as a Predictor of Subtherapeutic Posaconazole Levels. IDWeek 2023, 2023. e-Pub 2023.
- Khawaja F, Sassine J, Handley G, Prakash R, Angelidakis G, Ahmed S, Ramdial J, Yago N, Rondon G, Ariza Heredia E, Spallone A, Iyer S, Chemaly RF. Human Herpes Virus 6 DNAemia within 1 Year of Chimeric Antigen Receptor T Cell Therapy. TANDEM: Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR 2023, 2023. e-Pub 2023.
- Khawaja F, Prakash R, Sassine J, Handley G, Van Wieren T, Angelidakis G, Iyer SP, Ramdial JL, Ahmed S, Nieto Y, Spallone A, Ariza Heredia E, Chemaly R. Cytomegalovirus (CMV) Reactivation within in the First Year after Chimeric Antigen Receptor (CAR) T Cell Therapy: Experience from the First Two Years at a Major Cancer Center. The 64th American Society of Hematology Annual Meeting 2022, 2022. e-Pub 2022.
- Khawaja F, Sassine J, Handley G, Iyer SP, Ramdial J, Ahmed S, Nieto Y, Spallone A, Ariza Heredia E, Chemaly RF. Herpesviruses Infections in CAR T Cell Recipients. TANDEM: Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR 2022, 2022. e-Pub 2022.
- Handley GH, Hasbun R, Okhuysen PC. A Review of Human Herpesvirus 6 and Central Nervous System Disease in Oncology Patients. IDWeek 2020, 2020. e-Pub 2020.
- Wells JM, Sullivan DI, Xu X, Szul T, Jones CW, Handley G, Bailey WC, Blalock JE, Jackson PL. Emerging Tobacco Products: Toxicant Chemical Release and Stimulation of Neutrophilic Pulmonary Inflammation. American Thoracic Society 2013 International Conference, 2013. e-Pub 2013.
- Angelidakis G, Khawaja F, Zubovskaia A, Sassine J, Ramdial JL, Ahmed S, Iyer SP, Rondon G, Handley G, Van Wierren T, Ariza Heredia E, Spallone A, Shpall EJ, Chemaly RF. Comparing infectious complications following CD19 chimeric antigen receptor T cell therapy and autologous hematopoietic cell transplantation in patients with hematologic malignancies. International Immunocompromised Host Society 24th Biennial Symposium.
- Handley G, Feldman A, Powell J, Bhatti M, Chemaly R, Spallone A. A Decade of Invasive Mold Infections in Patients with Hematologic Malignancies: Insights from an Infection Control Surveillance Program at an NCI-Designated Comprehensive Cancer Center. International Immunocompromised Host Society 24th Biennial Symposium.
- Handley G, Spallone S, Khawaja F, Ahmed S, John TM, Iyer SP, Rondon G, Patel KK, Strati P, Chemaly RF. Risk Stratification for Severe Bacterial Infection Utilizing the CAR-HEMATOTOX Score. International Immunocompromised Host Society 24th Biennial Symposium.
Book Chapters
- Eatrides, J, Handley, GH. Microorganism-Induced Benign Hematologic Conditions. In: Non-Neoplastic Hematologic Disorders. 1. Springer Cham, 715-734, 2024.
- Handley, GH. Epstein-Barr Virus: Acute Infection, Oncogenesis, Prevention and Pitfalls. In: Global Virology IV: Viral Disease Diagnosis and Treatment Delivery in the 21st Century. 1. Springer Cham, 167-188, 2024.
- Handley, GH. Human Herpesvirus 6A, 6B, 7, and 8 in Hematopoietic Stem Cell Transplant: A Clinical Review. In: Global Virology IV: Viral Disease Diagnosis and Treatment Delivery in the 21st Century. 1. Springer Cham, 189-200, 2024.
- Handley, GH, Ostrosky-Zeichner, L. Antifungal Therapy in the Surgical Patient. In: Current Surgical Therapy. 14. Elsevier, 1491-1500, 2023.
- Handley, GH, Hand, J. Adverse Effects of Immunosuppression. In: Pharmacology of Immunosuppression. 1. Springer Nature Switzerland AG, 287-314, 2022.
- Handley G. Adjunct Corticosteroid Therapy for Patients with Community Acquired Pneumonia. In: Clinical Approaches to Hospital Medicine. 1. Springer International Publishing AG, 45-54, 2018.
Letters to the Editor
- Handley G, Pasikhova Y, Hill JA. Letter to the Editor Regarding "Once-Daily Foscarnet Is Effective for Human Herpesvirus 6 Reactivation after Hematopoietic Stem Cell Transplantation". Transplant Cell Ther 29: 645-646, 2023.
Patient Reviews
CV information above last modified August 20, 2026